<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Invest Ophthalmol Vis Sci</journal-id><journal-id journal-id-type="iso-abbrev">Invest Ophthalmol Vis Sci</journal-id><journal-id journal-id-type="pmc-domain-id">1229</journal-id><journal-id journal-id-type="pmc-domain">iovs</journal-id><journal-id journal-id-type="publisher-id">IOVS</journal-id><journal-title-group><journal-title>Investigative Ophthalmology &amp; Visual Science</journal-title></journal-title-group><issn pub-type="ppub">0146-0404</issn><issn pub-type="epub">1552-5783</issn><publisher><publisher-name>Association for Research in Vision and Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12429706</article-id><article-id pub-id-type="pmcid-ver">PMC12429706.1</article-id><article-id pub-id-type="pmcaid">12429706</article-id><article-id pub-id-type="pmcaiid">12429706</article-id><article-id pub-id-type="pmid">40928310</article-id><article-id pub-id-type="doi">10.1167/iovs.66.12.25</article-id><article-id pub-id-type="publisher-id">IOVS-25-42722</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Visual Neuroscience</subject></subj-group><subj-group subj-group-type="category"><subject>Visual Neuroscience</subject></subj-group></article-categories><title-group><article-title>Inner Limiting Membrane Peel Extends In Vivo Calcium Imaging of Retinal Ganglion Cell Activity Beyond the Fovea in Non-Human Primate</article-title><alt-title alt-title-type="runhead">Ca<sup>2+</sup> Imaging of Retinal Neurons Beyond the Fovea</alt-title><alt-title alt-title-type="left-running">Ca<sup>2+</sup> Imaging of Retinal Neurons Beyond the Fovea</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Baez</surname><given-names initials="HC">Hector C.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>LaPorta</surname><given-names initials="JM">Jennifer M.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Walker</surname><given-names initials="AD">Amber D.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fischer</surname><given-names initials="WS">William S.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hollar</surname><given-names initials="R">Rachel</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patterson</surname><given-names initials="SS">Sara S.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DiLoreto</surname><given-names initials="DA">David A.</given-names><suffix>Jr</suffix></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gullapalli</surname><given-names initials="V">Vamsi</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>McGregor</surname><given-names initials="JE">Juliette E.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><aff id="aff1"><label>1</label>Department of Biomedical Engineering, University of Rochester, Rochester, NY, United States</aff><aff id="aff2"><label>2</label>Center for Visual Science, University of Rochester, Rochester, NY, United States</aff><aff id="aff3"><label>3</label>Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Correspondence: Juliette E. McGregor, Center for Visual Science, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA; <email>jmcgrego@ur.rochester.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>66</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">496268</issue-id><elocation-id>25</elocation-id><history><date date-type="accepted"><day>09</day><month>7</month><year>2025</year></date><date date-type="received"><day>14</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>10</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="iovs-66-12-25.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="iovs-66-12-25.pdf"/><abstract><sec><title>Purpose</title><p>Adaptive optics scanning light ophthalmoscopy (AOSLO) paired with intravitreal injection of a viral vector coding for the calcium indicator GCaMP has enabled visualization of neuronal activity in retinal ganglion cells (RGCs) at single cell resolution in the living eye. However, the inner limiting membrane (ILM) restricts viral transduction to the fovea in humans and non-human primates, hindering both therapeutic intervention and physiological study of the retina. To address this issue, we explored peeling the ILM before intravitreal injection to expand calcium imaging beyond the fovea in the living primate eye.</p></sec><sec><title>Methods</title><p>Five eyes from three <italic toggle="yes">Macaca fascicularis</italic> (aged 3&#8211;10 years; 2 males, 1 female) that were immune suppressed with cyclosporine, underwent vitrectomy and ILM peel centered on the fovea prior to intravitreal delivery of 7m8:SNCG:GCaMP8. RGC responses to visual flicker were evaluated using AOSLO calcium imaging 1 to 6 months after intravitreal injection.</p></sec><sec><title>Results</title><p>Calcium activity was observed in RGCs throughout the ILM peeled area in all eyes, representing a mean eight-fold increase in accessible recording area relative to a representative control eye. RGC responses in the ILM peeled and control eyes were comparable and showed no significant decrease over the 6 month period after the procedure. In addition, we demonstrated that activity can be recorded directly from the retinal nerve fiber layer.</p></sec><sec><title>Conclusions</title><p>Peeling the ILM is a viable strategy to expand viral access to RGCs for gene therapy, and when paired with GCaMP imaging has the potential to advance visual neuroscience, preclinical evaluation of retinal function, detection of vision loss, and assessment of therapeutic interventions.</p></sec></abstract><kwd-group><kwd>GCaMP</kwd><kwd>AOSLO</kwd><kwd>RGC</kwd><kwd>ILM peel</kwd><kwd>calcium imaging</kwd><kwd>in vivo</kwd><kwd>retinal imaging</kwd></kwd-group><counts><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>The retina is a highly specialized tissue in the back of the eye that plays a critical role in the capture and processing of visual information. Advances in methods to study retinal function have enhanced our ability to understand retinal physiology,<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> disease,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> and to evaluate and optimize therapeutic interventions.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> In vivo measures of function allow us to gain insight into retinal activity in an intact tissue with the integrity of both circuitry and bodily systems maintained.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> This is particularly important for preclinical development where the immune system may be provoked by the intervention.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Furthermore, in vivo recording enables indefinite longitudinal follow-up. The non-human primate (NHP) is the gold standard animal model for both retinal physiology and preclinical testing of novel therapies, owing to the close similarity between the visual<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> and immune systems of NHPs and humans.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> In vivo measures of function are, therefore, particularly appealing in NHPs, where numbers are few but the potential for translation is high.</p><p>The ideal in vivo functional testing paradigm would evaluate neuronal activity at the cellular scale throughout the retina. Multielectrode array and patch clamp electrophysiology in retinal explants allow recordings with high temporal resolution, but rapid degradation of the explant precludes longitudinal measurements in a single individual. This complicates assessment of pathologies and therapies, particularly when the time course is uncertain.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref><sup>,</sup><xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Electoretinography enables repeated non-invasive measurement of retinal responses in vivo,<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> but does not readout activity at the cellular scale. Behavioral testing can complement optical and electrophysiological studies,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> but does not provide direct insight into function at the retinal level or at the cellular scale.</p><p>By pairing adaptive optics scanning laser ophthalmoscopy (AOSLO), which enables high-resolution retinal imaging,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> with viral vector mediated expression of the genetically encoded calcium indicator GCaMP, it is now possible to optically read out retinal ganglion cell (RGC) activity at the cellular scale in NHP in vivo.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="bib17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> However, viral transduction of the ganglion cell layer (GCL) after intravitreal injection of an adeno-associated virus (AAV) has previously been spatially restricted to a ring of RGCs serving the most central foveal cones in primates.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> This is because the inner limiting membrane (ILM), a thin border between the retina and vitreous fluid formed by astrocytes and end feet of M&#252;ller cells, creates a barrier to viral penetration outside of the foveal pit.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Peeling the ILM before intravitreal injection has reliably expanded viral transduction of Green Fluorescent Protein in retinal neurons,<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>&#8211;</sup><xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> and this approach has been proposed as a strategy to dramatically expand the area of RGCs transduced by gene therapies. Peeling of the ILM has been associated with mild edema caused by the surgical procedure itself, swelling of the arcuate nerve fiber layer,<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> dissociated optic nerve fiber layer,<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> and intraretinal edema<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> that, although minor, could be worsened by viral transduction.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref></p><p>In this study, we dramatically expand the area of the NHP retina accessible for optical recording of function in vivo by removing the ILM before intravitreal injection of the viral vector coding for GCaMP. Not only does this approach expand the potential usefulness of this optical recording platform in vivo, but it also provides insight into the impact of the ILM procedure on the retina at the cellular scale in the living eye. We obtained RGC responses at eccentricities that were previously inaccessible, in multiple animals, over months and present the first optical recordings from the retinal nerve fiber layer (RNFL). Additionally, a comprehensive assessment of concomitant inflammation was performed to better understand the outcomes associated with pairing the ILM peel procedure with a viral vector injection.</p><sec sec-type="methods" id="sec2"><title>Materials and Methods</title><sec id="sec2-1"><title>Experimental Design</title><p>Five experimental eyes and one control eye from three <italic toggle="yes">Macaca fascicularis</italic> (two male, one female) were used in this study. All five experimental eyes were vitrectomized and underwent peeling of the ILM centered on the fovea (<xref rid="fig1" ref-type="fig">Figs.&#160;1</xref>A&#8211;B). Six to eight weeks later, an intravitreal injection of a viral vector was performed to produce GCaMP expression in the ganglion cell layer (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>C). Three of the five experimental eyes received an intravitreal injection of viral vector AAV2.7m8-SNCG-GCaMP8s, while the two eyes of macaque M3 received the GCaMP8m variant. One control eye did not undergo vitrectomy or ILM peeling (<xref rid="tbl1" ref-type="table">Table 1</xref>). We did not perform a vitrectomy without an ILM peel as an additional control because previous studies have established that vitrectomy alone was insufficient to extend viral transduction.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Confocal scanning laser ophthalmoscopy (cSLO) confirmed the presence of GCaMP in the area corresponding with the region of the surgical ILM peel (<xref rid="fig1" ref-type="fig">Fig.&#160;1</xref>D). cSLO, optical coherence tomography (OCT), and color fundus photography were performed longitudinally for up to 6 months after the procedure. Functional assessment in vivo was conducted using fluorescence AOSLO in combination with a red LED flicker stimulus (<xref rid="fig1" ref-type="fig">Figs.&#160;1</xref>E&#8211;G). Retinal imaging was conducted between the fovea and the ILM peel edge in all meridians.</p><fig position="float" id="fig1" orientation="portrait"><label>Figure 1.</label><caption><p>Overview of Study. (<bold>A</bold>) Following a pars plana vitrectomy, the ILM was stained with brilliant blue dye. (<bold>B</bold>) Mechanical force lifts the ILM in a circular pattern around the fovea using forceps. (<bold>C</bold>) Intravitreal injection delivers viral vector to the retina. (<bold>D</bold>) A blue autofluorescence (BAF) confocal scanning laser ophthalmoscope (cSLO) confirmed the presence of GCaMP in a pattern matching the surgical peel two months post injection. (<bold>E</bold>) Functional assessments were conducted at retinal imaging locations using a blue 488-nm excitation source in combination with a red LED flashing stimulus. (<bold>F</bold>) Individual RGCs were segmented and <bold>(G)</bold> Their responses to the LED stimulus tabulated.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f001.jpg"/></fig><table-wrap position="float" content-type="8col" id="tbl1" orientation="portrait"><label>Table 1.</label><caption><p>Summary of Demographic and Experimental Parameters for all Eyes Involved in the Study</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Macaque (Eye)</th><th rowspan="1" colspan="1">Sex</th><th rowspan="1" colspan="1">Age at Time of ILM Peel</th><th rowspan="1" colspan="1">Inactivating Antibodies to AAV2</th><th rowspan="1" colspan="1">Time Between Immune Suppression and ILM Peel (Days)</th><th rowspan="1" colspan="1">Time Between ILM Peel and Viral Vector Injection (Days)</th><th rowspan="1" colspan="1">Time of AAV2 Injection After Initial Injection in Fellow Eye (Days)</th><th rowspan="1" colspan="1">GCaMP Variant</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">M1 (OS)</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">1:4</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">GCaMP8s</td></tr><tr><td rowspan="1" colspan="1">M1 (OD)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">10 y 9 m</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">31</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">GCaMP8s</td></tr><tr><td rowspan="1" colspan="1">M2 (OS)</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">4 y 2 m</td><td rowspan="1" colspan="1">1:5</td><td rowspan="1" colspan="1">27</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">GCaMP8s</td></tr><tr><td rowspan="1" colspan="1">M2 (OD)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">4 y 3 m</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">55</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">GCaMP8s</td></tr><tr><td rowspan="1" colspan="1">M3 (OS)</td><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">3 y 10 m</td><td rowspan="1" colspan="1">1:10</td><td rowspan="1" colspan="1">98</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">35</td><td rowspan="1" colspan="1">GCaMP8m</td></tr><tr><td rowspan="1" colspan="1">M3 (OD)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3 y 11 m</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">126</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">&#8212;</td><td rowspan="1" colspan="1">GCaMP8m</td></tr></tbody></table><table-wrap-foot><fn id="tb1fn1"><p>The sex and age of the primate, immune suppression status, quantity, and type of viral vector injected intravitreally, and the time elapsing between the ILM peel and the intravitreal injection in days is listed for each eye.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-2"><title>Animal Welfare</title><p>The macaques used in this study were housed in pairs in an Association for Assessment and Accreditation of Laboratory Animal Care&#8211;accredited facility in compliance with the University of Rochester University Committee on Animal Resources. They had free access to water and primate biscuits, providing a complete and nutritious diet. To supplement this, they were given various treats multiple times daily, such as nuts, dried fruit, vitamin chews, and a large variety of fresh fruits and vegetables. They were also given high-value treats during training, including Ensure, marshmallow snacks, and fruit gummies. An animal behaviorist and veterinary technicians provided novel enrichment items multiple times a week, including items such as grass, oranges with peels still on, treat-filled forage boxes, grapevines, water play, and popcorn balls. Daily enrichment included mirrors, puzzle feeders, durable chew toys, daily television time and/or music, and regular visits from staff to offer treats and socialization. All macaques were cared for by the Department of Comparative Medicine veterinary staff, including three full-time veterinarians, five veterinary technicians, and care staff who monitored animal health and comfort at least three times daily. The animal behaviorist regularly recorded and analyzed primate behavior to monitor any signs of stress. This study was carried out in strict accordance with the ARVO Statement for the Use of Animals and the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the University Committee on Animal Resources of the University of Rochester (PHS assurance number: D16-00188[A3292-01]).</p></sec><sec id="sec2-3"><title>Immunosuppression</title><p>All macaques in this experiment received subcutaneous cyclosporine injections daily. Blood trough levels were collected to titrate the dose to 150 to 250 ng/mL, and this level was maintained for the duration of the experiment. The timings of immune suppression relative to the ILM peel surgery and viral vector injections are detailed in&#160;<xref rid="tbl1" ref-type="table">Table 1</xref>.</p></sec><sec id="sec2-4"><title>Animal Preparation for ILM Peel Surgery</title><p>The surgical subject was fasted overnight with free access to water. The animal was sedated using ketamine (100 mg/mL) and medetomidine (20 mg/mL), then intubated and kept at proper anesthetic depth via 1.5% to 3% isoflurane throughout the procedure. The animal was positioned in dorsal recumbency on a padded surgical table. A Bair Hugger warming system was placed over the animal to maintain body temperature. Vital signs including temperature, heart rate and rhythm, respirations, end tidal CO<sub>2</sub>, blood pressure, SpO<sub>2</sub>, and reflexes were monitored continuously and recorded every 15 minutes. Pupil dilation was accomplished using 1% atropine ophthalmic solution. An aseptic preparation was performed on the surgical eye and surrounding area using 5% betadine solution and flushed with sterile 0.9% saline. The subject's eye and body were then draped in a sterile fashion.</p></sec><sec id="sec2-5"><title>ILM Peel Procedure</title><p>The ILM peel procedures performed in NHP closely followed the protocol used in human surgery. A standard 3-port pars plana vitrectomy was performed through 25G cannulas using the Constellation vitrectomy system (Alcon, Fort Worth, TX, USA), OPMI Lumera 700 operating microscope, and RESIGHT viewing system (Carl Zeiss Meditec AG, Jena, Germany). Triamcinolone was injected intravitreally to visualize the vitreous. A posterior vitreous detachment was induced using aspiration from the vitrector or a soft tip cannula. The peripheral vitreous was trimmed. Brilliant Blue G Ophthalmic Solution (DORC, Zuidland, the Netherlands) was placed over the macula and the ILM was stained for 2 minutes (<xref rid="iovs-66-12-25_s002" ref-type="supplementary-material">Supplementary Movie 1</xref>). A fluid&#8211;fluid exchange was performed to remove the dye. The stained ILM was then peeled 360&#176;, in an approximately 5- to 6-disc diameter area (13&#8211;24 mm<sup>2</sup>) centered on the macula, using ILM peeling forceps (Alcon) (<xref rid="iovs-66-12-25_s002" ref-type="supplementary-material">Supplementary Movie 1</xref>). The three ports were removed at the end of the surgery and the sclerotomies sutured. The animal was given an intravitreal injection of the antibiotics vancomycin (1 mg/0.1 mL) and ceftazidime (2 mg/0.1 mL). The immunosuppressant cyclosporine (150&#8211;250 ng/mL), anti-inflammatory meloxicam (5 mg/mL), analgesic buprenorphine SR (3 mg/mL), and an anesthetic reversal of antisedan (5 mg/mL) were administered postoperatively.</p></sec><sec id="sec2-6"><title>Intravitreal Injection of the Viral Vector</title><p>Intravitreal injection of AAV2-7m8.SNCG.jGCaMP8s.WPRE.SV40 (100 &#181;L at titer 2.62 &#215; 10<sup>13</sup> GC/mL) or AAV2-7m8.SNCG.jGCaMP8m.WPRE.SV40 (100 &#181;L at titer &#8805;2.46 &#215; 10<sup>13</sup> GC/mL), was performed as previously described in Yin et al. (2011).<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Briefly, the eye was sterilized with 5% diluted betadine before the vector was injected into the vitreous through the pars plana using a tuberculin syringe and a 30G needle. All viral vectors were synthesized by the University of Pennsylvania Vector Core. Neutralizing antibodies to AAV2 were 1:25 or lower in all four injected animals before the study. After intravitreal injection of the vector, each eye was imaged weekly with a conventional scanning light ophthalmoscope (Heidelberg Spectralis, Heidelberg Engineering, Franklin, MA, USA) using the blue autofluorescence modality, to determine the onset of expression, and to monitor eye health. Animals received 2 mg/0.05 mL of triamcinolone intravitreally (Kenalog-40) after the injection to treat symptoms of uveitis.</p></sec><sec id="sec2-7"><title>Animal Preparation for Imaging</title><p>All animals were fasted from 4 to 18&#8201;h before anesthesia induction. Anesthesia induction began with 5 to 20&#8201;mg/kg&#160;ketamine, 0.25&#8201;mg/kg&#160;midazolam, and 0.017&#8201;mg/kg&#160;glycopyrrolate intramuscularly. The pupil was dilated with a combination of tropicamide 1% and phenylephrine 2.5%. In cases of minimal pupil dilation within the standard time, phenylephrine 10% and/or cyclopentolate 1% drops were administered. Flurbiprofen ophthalmic drops are given to the target eye, to prevent any discomfort from prolonged use of an eye lid speculum. Both eyes were covered with a hydrating ophthalmic gel (GenTeal; Alcon). The target eye then had the lid speculum placed to keep the eye open during imaging and a contact lens was placed to ensure corneal protection. The fellow eye was taped closed with porous tape, to protect the cornea from drying.</p><p>The animal was placed in a stereotaxic cart. Before intubation, an oxygen mask with 1% to 2% isoflurane, was placed over the monkey's face to allow for adequate sedation for intubation. An intravenous drip of lactated Ringers with 5% dextrose was maintained at 5&#8201;mL/kg/h&#160;for the duration of imaging. The monkey was intubated and maintained at a surgical plane of anesthesia with isoflurane 1.0% to 2.5%. A Bair Hugger warming system was placed over the monkey to maintain body temperature. Monitoring was conducted as previously described.</p><p>After a surgical plane of anesthesia had been established, a Rocuronium constant rate infusion (800&#160;&#181;g/mL) was given with an initial bolus dose of 100 to 400 &#181;g/kg, followed by a dose range from 200 to 600&#160;&#181;g/kg/h. The lowest effective dose of rocuronium needed to control eye movement in each animal was administered. Once respirations ceased, the monkey was maintained on a ventilator until imaging was over and the infusion was turned off. Once a peripheral nerve response was established, an intravenous dose of glycopyrrolate 0.01&#8201;mg/kg&#160;was given. Five minutes after the glycopyrrolate, neostigmine 0.05&#8201;mg/kg&#160;was given intravenously. The animal was monitored for indications of breathing against the ventilator and then removed from the ventilator once able to breath without assistance. The animal was removed from the isoflurane no sooner than 15 minutes after the neostigmine injection to ensure stability off the ventilator. The animal was then allowed to wake up and extubated once all reflexes had returned.</p></sec><sec id="sec2-8"><title>Clinical Imaging</title><p>cSLO, OCT, and color fundus photography were performed before and after the procedure using a commercially available Spectralis HRA (Heidelberg Engineering) and fundus camera (Topcon 50EX). The blue autofluorescence modality on the Spectralis HRA was used to capture GCaMP fluorescence using the 488nm excitation wavelength and a longpass filter at 500 nm. GCaMP fluorescence was also captured using a fundus camera equipped with filters selective for GCaMP (excitation 472/30 nm emission 520/28 nm). We collected 30&#176; and 55&#176; cSLO images centered on the fovea before and after ILM peel, before and after intravitreal injection, and approximately every 30 days thereafter. OCT data from the optic nerve head in addition to slit lamp photographs (Zeiss) were recorded at the same timepoints to document the time course and severity of any inflammation.</p></sec><sec id="sec2-9"><title>Assessing Ocular Inflammation</title><p>A modified Hackett&#8211;McDonald scoring system<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> was used to evaluate ocular inflammation. A veterinary technician evaluated pupil reflex and conjunctival discharge before pupil dilation. A comprehensive set of slit lamp images were recorded, randomized and graded by a masked ophthalmologist (V.G.). The scoring system is provided in the <xref rid="iovs-66-12-25_s001" ref-type="supplementary-material">Supplementary Materials</xref>.</p></sec><sec id="sec2-10"><title>Calcium Imaging Adaptive Optics cSLO</title><p>AOSLO data were collected using a previously described AOSLO instrument.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> An 847-nm diode laser (QPhotonics, 100&#8211;136 &#181;Wmm<sup>&#8722;2</sup>) was used as a wavefront sensing beacon in combination with a Shack-Hartman wavefront sensor and a deformable mirror (ALPAO) for measuring and correcting the optical aberrations of the eye. A 796-nm superluminescent diode (Superlum, 57 &#181;Wmm<sup>&#8722;2</sup>) was used to image the cone photoreceptor layer using a 2 airy disc (20-&#181;m) pinhole to collect the reflected light. Simultaneously, a 488-nm laser (Qioptiq, 57 &#181;Wmm<sup>&#8722;2</sup>) focused on the RGC layer was used to excite GCaMP and emitted fluorescence was collected using a 7.5 airy disc (75 &#181;m) pinhole. This excitation laser produced a light intensity of approximately 100 nWmm<sup>&#8722;2</sup> at the photoreceptor layer. Laser powers were calibrated before every imaging session to ensure consistency across sessions. To correct for longitudinal chromatic aberration between the 796-nm source, the 488-nm source, and the emitted fluorescence, motorized stages were adjusted to optimize the source and detector positions in vivo before each experiment. The adaptive optics control facilitated fine focus on the retinal ganglion layer. We recorded GCaMP fluorescence from RGCs within each 2.54&#176; &#215; 2.54&#176; field of view as a 7&#176; uniform visual stimulus was presented through a Maxwellian view system.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> An LED (Thorlabs, Newton, NJ, USA) with a 661/20-nm emission filter was used as the visual stimulus to avoid the GCaMP excitation spectrum. The visual stimulus consisted of 20-second contrast increments and decrements against a mean light level (3 &#181;Wmm<sup>&#8722;2</sup> or 15.0 log quanta&#183;cm<sup>&#8722;2</sup>&#183;s<sup>&#8722;1</sup>, 0.33 Michaelson contrast). Because we are using a large 2.5&#176; &#215; 2.5&#176; field of view, some photoreceptors received light from both the 488 nm imaging laser and the 661 nm visual stimulus, reducing the effective Michaelson contrast, particularly at high eccentricities where the Henle fibers are shorter and there is more overlap between the 488-nm excitation laser and the photoreceptors.</p><p>Trials began with a 60-second system background period with no laser emission, followed by a 120-second light adaptation period to the 488-nm imaging laser and the mean luminance of the visual stimulus before the 20-second increments and decrements began. The stimulus was designed primarily to yield robust responses despite the relatively low signal to noise ratio of in vivo calcium imaging. Measuring the response over the full 20 seconds for most cells gave us a larger window of integration for quantification of ON and OFF responses and increased the likelihood that we would identify differences in response strength between the control and ILM&#8211;peel eyes. Each trial was repeated twice at each retinal location. Total exposure to all laser sources was kept below the Rochester exposure limit,<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> designed to be two-fold more conservative than the 2014 American National Standards Institute standard.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></p></sec><sec id="sec2-11"><title>Data Analysis</title><p>The intensity profiles shown in&#160;<xref rid="fig1" ref-type="fig">Figures 1</xref>A&#8211;B show image brightness along the dashed lines, spanning 25&#176; through the animal's foveal center. Each intensity profile was independently normalized by scaling the intensity value to the maximum pixel intensity within each image, resulting in values from 0 to 1. To reduce noise, a 50-point moving average filter was applied to smooth the trace.</p><p>To quantify the area of GCaMP expression, we used FIJI/ImageJ<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> to manually segment the bright region corresponding to extrinsic fluorescence in 25 degree cSLO images (blue autofluorescence modality). The contrast of the images was adjusted to maximize the discriminability of this region relative to retinal autofluorescence, and the boundary was then manually traced with the freehand tool. Degrees were converted to mm by scaling a model human eye (24 mm) to the individual NHP axial length (17.7 mm). The measure function in FiJI was used to calculate the segmented area in square millimeters. These segmentation masks closely corresponded with the extent of the ILM peel captured in the surgical video. An example of this correspondence is shown in&#160;<xref rid="fig1" ref-type="fig">Figures 1</xref>B and&#160;<xref rid="fig1" ref-type="fig">1</xref>D.</p><p>Adaptive optics calcium imaging data was stored as an uncompressed AVI video format. Stimulus information was written frame by frame to a csv file, providing an accurate record for analysis. The reflectance videos of the photoreceptor mosaic were registered offline using a strip-based cross-correlation algorithm<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> that corrected translational motion between frames and intraframe warping due to retinal motion. Each frame of the GCaMP fluorescence video was coregistered to the photoreceptor reflectance video. The frames of the fluorescence video were temporally integrated to form a high signal-to-noise ratio <italic toggle="yes">z</italic> projection image that was used to create an RGC segmentation mask using FIJI.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> RGC segmentation masks were imported into MATLAB and used to tabulate individual cell traces for each imaging location. These cell traces were filtered using a 50-frame moving median filter. The instantaneous <italic toggle="yes">z</italic>-score values were calculated as the GCaMP response amplitude (signal) minus the mean amplitude of the last 20 seconds of the 120-second prestimulus baseline adapted response (noise), all divided by the standard deviation of the noise. Cell responses were classified as ON center or OFF center and time averaged in the corresponding regions to calculate an overall cell <italic toggle="yes">z</italic>-score. Final <italic toggle="yes">z</italic>-scores were computed using only the relevant (ON or OFF) response periods for each cell. The stimulation paradigm and example responses are shown in <xref rid="iovs-66-12-25_s001" ref-type="supplementary-material">Supplementary Figure S1</xref>. The criterion for a responsive cell was set to 2.5 standard deviations above the noise. Statistical analyses were performed using MATLAB two-sample <italic toggle="yes">t</italic> test, with group spread reported as the mean &#177; SD.</p><p>To record from the RNFL near the optic disc we used the same imaging and stimulation paradigm that was used for RGCs. We integrated a large area encompassing multiple passing fibers to enable extraction of population-level responses.</p></sec><sec id="sec2-12"><title>Code and Data Accessibility</title><p>All code used for analysis and corresponding filtered RGC recordings are made available on the open science framework repository <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://osf.io/dwck8/" ext-link-type="uri">https://osf.io/dwck8/</ext-link>. Raw video data, owing to size, are available upon request.</p></sec></sec><sec sec-type="results" id="sec3"><title>Results</title><sec id="sec3-1"><title>ILM Peel Enables Functional Recording From RGCs at Previously Inaccessible Eccentricities In Vivo</title><p>To assess the impact of ILM peel on the spatial extent of GCaMP transduction in the GCL, we directly compared the pattern of expression in the ILM peeled eye with the fellow eye of the same animal (M1), which received an intravitreal injection but no ILM peel (control).&#160;<xref rid="fig2" ref-type="fig">Figures 2</xref>A and&#160;<xref rid="fig2" ref-type="fig">2</xref>B show a 5-fold increase in the area of GCaMP expressing RGCs in the ILM peeled eye (12.9 mm<sup>2</sup>) relative to the control (2.5 mm<sup>2</sup>). In the ILM peeled eye, RGCs were transduced with GCaMP out to 9.2&#176; superior to the fovea, whereas in the control eye the maximum eccentricity was just 3.5&#176;. The increased fluorescence relative to the autofluorescent background observed in&#160;<xref rid="fig2" ref-type="fig">Figure 2</xref>B extended to the limit of the ILM peel identified by retinal landmarks in the surgical video. Furthermore, imaging with a fluorescence fundus camera equipped with filters selective for GCaMP excitation and emission confirmed that the elevated fluorescence was the extrinsic fluorophore GCaMP.</p><fig position="float" id="fig2" orientation="portrait"><label>Figure 2.</label><caption><p>ILM peeling enables AAV-mediated fluorescence beyond the fovea in macaque. (<bold>A</bold>) 30&#176;cSLO BAF images centered on the fovea, taken in each eye of M1 including the (<bold>A</bold>) control eye OS and (<bold>B</bold>) the ILM peeled eye OD. GCAMP Fluorescence intensity contour (visualized in the <italic toggle="yes">bottom</italic>, line denoted by a <italic toggle="yes">white dashed line</italic>) is normalized to the maximum value and smoothed. AOSLO Imaging locations are labeled for each eye. (<bold>C</bold>) Box plot of individual RGC <italic toggle="yes">z</italic>-scores at each imaging location, grouped by retinal eccentricity. Group responses for M1 OD are 6.4 &#177; 4.4 (<italic toggle="yes">n</italic> = 77) (ON = 18; OFF = 59); 11.52 &#177; 7.5 (n = 85) (ON = 36; OFF = 49); 6.4 &#177; 3.9 (<italic toggle="yes">n</italic> = 40) (ON = 14; OFF = 26). Group responses for the control eye (M1 OS) are 10.0 &#177; 6.6 (<italic toggle="yes">n</italic> = 62) (ON = 42; OFF = 20); 10.9 &#177; 7.6 (<italic toggle="yes">n</italic> = 73) (ON = 45; OFF = 28); respectively. Taken at 17 weeks after intravitreal injection in OS and 21 weeks OD.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f002.jpg"/></fig><p>To assess the responses of RGCs in the ILM peeled and control eyes, we performed calcium imaging AOSLO while the retina received periodic visual stimulation at 0.025 Hz.&#160;<xref rid="fig1" ref-type="fig">Figure 1</xref>G shows an example fluorescence trace from a single ON cell in the ILM peeled eye. The magnitudes of single cell responses recorded in the ILM peeled and control eyes are shown in&#160;<xref rid="fig2" ref-type="fig">Figure 2</xref>C, represented as <italic toggle="yes">z</italic>-scores. The distribution of <italic toggle="yes">z</italic>-scores from individual RGCs in the ILM peeled and control eyes were not significantly different 3.5&#176; (<italic toggle="yes">P</italic> = 0.61), suggesting that the ILM peel did not adversely impact RGC physiology at this eccentricity. Importantly, only in the ILM-peeled eye was it possible to obtain functional recording from RGCs at eccentricities beyond 3.5&#176;.&#160;<xref rid="fig2" ref-type="fig">Figure 2</xref>C shows responses collected from RGCs at 9.2&#176; from the foveal center. This was the first time in vivo calcium imaging had been performed outside the parafovea. No RGCs fluoresced beyond 4&#176; from the fovea in the control eye (M1 OS). The <italic toggle="yes">z</italic>-scores from M1 OD at 9.2&#176; were found to be significantly lower than those at 3.5&#176; in the same eye (<italic toggle="yes">P</italic> = 0.0004).</p><p>Because functional recordings were obtained in vivo, it was possible to return to the same region of the GCL to longitudinally monitor RGC responses over a period of months (<xref rid="fig3" ref-type="fig">Fig.&#160;3</xref>). For M1 OD, RGC response amplitudes at 9&#176; did not significantly change over time (<xref rid="fig3" ref-type="fig">Figs. 3</xref>A,&#160;<xref rid="fig3" ref-type="fig">3</xref>B; paired <italic toggle="yes">t</italic> test; <italic toggle="yes">P</italic> = 0.86, <italic toggle="yes">P</italic> = 0.42), but the amplitudes at 3&#176; significantly increased after 5 months (<xref rid="fig3" ref-type="fig">Figs. 3</xref>C,&#160;<xref rid="fig3" ref-type="fig">3</xref>D; paired <italic toggle="yes">t</italic> test; <italic toggle="yes">P</italic> = 0.02). Compared to the non-ILM peeled fellow eye at 3.5&#176; (<xref rid="fig3" ref-type="fig">Figs. 3</xref>E,&#160;<xref rid="fig3" ref-type="fig">3</xref>F) that was injected first, OD had significantly higher amplitudes (paired <italic toggle="yes">t</italic> test; <italic toggle="yes">P</italic> = 0.021). Although responses varied from week to week, no long-term decrease in the calcium responses of RGCs were observed, suggesting that RGC function was not significantly compromised by the ILM peel procedure.</p><fig position="float" id="fig3" orientation="portrait"><label>Figure 3.</label><caption><p>RGCs remain responsive for at least 6 months after ILM peel. (<bold>A</bold>) AOSLO GCaMP image used to create segmentation masks at the edge of the ILM peeled area at 9&#176; from the fovea of M1 OD. (<bold>B</bold>) Responses at 2 (6.7 &#177; 5.7; <italic toggle="yes">n</italic> = 27), 3 (6.0 &#177; 5.2; <italic toggle="yes">n</italic> = 28), and 5 (6.4 &#177; 4.0; <italic toggle="yes">n</italic> = 40) months after intravitreal injection, corresponding with 3, 4, and 6 months after ILM peel. (<bold>C</bold>) AOSLO GCaMP image within the ILM peeled area at 3.5&#176; from the fovea of M1 OD. (<bold>D</bold>) Responses at 3 (8.9 &#177; 6.2; <italic toggle="yes">n</italic> = 59), 4 (7.8 &#177; 6.6; <italic toggle="yes">n</italic> = 68), 5 (12.5 &#177; 10.2; <italic toggle="yes">n</italic> = 87), and 6 (11.5 &#177; 7.5; <italic toggle="yes">n</italic> = 76) months after intravitreal injection. (<bold>E</bold>) AOSLO GCaMP image at 3.5&#176; from the fovea of the control eye. (<bold>F</bold>) Responses at 1 (6.7 &#177; 3.5; <italic toggle="yes">n</italic> = 97), 2 (6.3 &#177; 3.2; <italic toggle="yes">n</italic> = 74), 3 (8.2 &#177; 2.9; <italic toggle="yes">n</italic> = 81), and 4 (10.7 &#177; 6.0; <italic toggle="yes">n</italic> = 75) months after intravitreal injection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f003.jpg"/></fig><p>To assess the reproducibility of this approach, an additional four eyes underwent ILM peeling before intravitreal injection of the viral vector and follow-up imaging. Relative to the control eye, we observed an average eight-fold increase in area of GCaMP expression. The area of expression was 2.5 mm<sup>2</sup> in the control eye, 12.9 mm<sup>2</sup> in the right eye (OD) of M1 (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>A), 24.4 mm<sup>2</sup> in the left eye (OS) of M2 (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>B), 20.1 mm<sup>2</sup> in M2 OD (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>C), 22.7 mm<sup>2</sup> in M3 OS (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>D), and 20.7 mm<sup>2</sup> in M3 OD (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>E). We extracted functional activity from RGCs in all eyes at eccentricities out to 9.2&#176; (M1 OD), 7.4&#176; (M2 OS), 7.9&#176; (M2 OD), 11&#176; (M3 OS), and 6.2&#176; (M3 OD). There was a significant decrease in response magnitude with eccentricity in M1 OD (<italic toggle="yes">P</italic> &lt; 0.01), but not in M2 OS (<italic toggle="yes">P</italic> = 0.60), M2 OD (<italic toggle="yes">P</italic> = 0.15), M3 OS (<italic toggle="yes">P</italic> = 0.06), and M3 OD (<italic toggle="yes">P</italic> = 0.12). We note that M2 had naturally occurring vessel tortuosity.</p><fig position="float" id="fig4" orientation="portrait"><label>Figure 4.</label><caption><p>RGC response amplitudes measured in all eyes. (<bold>A</bold>) (<italic toggle="yes">Left</italic>) 30&#176; cSLO BAF images centered on the fovea for all experimental eyes, imaging locations shown with <italic toggle="yes">blue squares</italic>. (<italic toggle="yes">Right</italic>) Individual RGC <italic toggle="yes">z</italic>-scores in box plots for M2 OD (6.4 &#177; 4.4 [<italic toggle="yes">n</italic> = 77], 11.5 &#177; 7.5 <italic toggle="yes">[</italic><italic toggle="yes">n</italic> = 85], and 6.4 &#177; 3.95 <italic toggle="yes">[</italic><italic toggle="yes">n</italic> = 40]) taken 5 months after intravitreal injection. (<bold>B</bold>) M2 OS (5.4 &#177; 2.5 [<italic toggle="yes">n</italic> = 12], 4.4 &#177; 2.9 [<italic toggle="yes">n</italic> = 17], 5.2 &#177; 3.3 [<italic toggle="yes">n</italic> = 30], and 4.4 &#177; 3.0 [<italic toggle="yes">n</italic> = 24]) taken 3 months after intravitreal injection. (<bold>C</bold>) M2 OD (7.3 &#177; 4.6 [<italic toggle="yes">n</italic> = 81], 7.1 &#177; 6.2 [<italic toggle="yes">n</italic> = 77], and 6.2 &#177; 3.7 [<italic toggle="yes">n</italic> = 48]) taken 5 months after intravitreal injection. (<bold>D</bold>) M3 OS (7.1 &#177; 4.3 [<italic toggle="yes">n</italic> = 52], 4.2 &#177; 1.5 [<italic toggle="yes">n</italic> = 31], 4.2 &#177; 2.1 [<italic toggle="yes">n</italic> = 12], and 4.9 &#177; 3.6 [<italic toggle="yes">n</italic> = 20]) taken 5 months after intravitreal injection. (<bold>E</bold>) M3 OD (8.3 &#177; 6.4 [<italic toggle="yes">n</italic> = 92] and 7.1 &#177; 4.4 [<italic toggle="yes">n</italic> = 99]) taken 6 months after intravitreal injection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f004.jpg"/></fig></sec><sec id="sec3-2"><title>Optical Readout of RGC Activity Is Possible From the RNFL</title><p>For the first time, we have shown that it is possible to record not only from RGC somas, but also from the RNFL near the optic disc (<xref rid="fig5" ref-type="fig">Fig.&#160;5</xref>). We evaluated calcium responses from the RNFL in both the ILM peeled and control eyes of M1. The investigated locations were outside of the ILM peeled area and as a result lacked fluorescing RGC somas, but did contain GCaMP-expressing axonal fibers (<xref rid="fig5" ref-type="fig">Figs. 5</xref> A, <xref rid="fig5" ref-type="fig">5</xref>C). The averaged signal from the integrated region (<xref rid="fig5" ref-type="fig">Figs. 5</xref>B,&#160;<xref rid="fig5" ref-type="fig">5</xref>D) corresponded with an OFF type response in both cases, but in the control eye the magnitude of the response was reduced by one-half (3.3 &#177; 0.02 in M1 OD and 1.4 &#177; 0.02 in the control) (<xref rid="fig5" ref-type="fig">Fig.&#160;5</xref>E).</p><fig position="float" id="fig5" orientation="portrait"><label>Figure 5.</label><caption><p>Optical readout of RGC activity from the RNFL. (<bold>A</bold>) 30&#176;cSLO BAF image centered on the fovea of M1 OD (ILM peeled). (<bold>B</bold>) AOSLO GCaMP image from the nasal location shown in (<bold>A</bold>). The green dotted line represents a 3.6&#176; &#215; 2.7&#176; area over which the signal was averaged to produce a response trace from the RNFL in M1 OD. (<bold>C</bold>) 30&#176;cSLO BAF image centered on the fovea of the control eye (M1 OS). (<bold>D</bold>) The <italic toggle="yes">orange dotted line</italic> represents a 3.6&#176; &#215; 2.7&#176; area over which the signal was averaged to produce a response trace from the RNFL in M1 OS. (<bold>E</bold>) RNFL responses to the visual stimulus in M1 OD (3.3 &#177; 0.02), and M1 OS, the control eye (1.4 &#177; 0.02).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f005.jpg"/></fig></sec><sec id="sec3-3"><title>Structural Imaging Reveals Minor Morphological Changes After ILM Peel</title><p>To ensure we had a full understanding of any structural changes in the retina resulting from the ILM peel, we closely monitored all eyes over time with fundus photography and OCT (<xref rid="fig6" ref-type="fig">Fig.&#160;6</xref>). Alteration of the foveal contour was visible in the B-scan OCT images of all subjects, with the extent of this alteration varying between individuals. The foveal pit diameter of M1 OD (<xref rid="fig6" ref-type="fig">Fig.&#160;6</xref>A) and M3 OD (<xref rid="fig6" ref-type="fig">Fig.&#160;6</xref>E) appears slightly reduced compared with before the ILM peel, whereas the foveal contours of M2 (<xref rid="fig6" ref-type="fig">Figs. 6</xref>B,&#160;<xref rid="fig6" ref-type="fig">6</xref>C) and M3 OS (<xref rid="fig6" ref-type="fig">Fig.&#160;6</xref>D) were more dramatically altered. These changes in foveal contour persist throughout the observation period (6 months after ILM peel). No macular holes were created, but disruption to the photoreceptor layer was noted in M2 OS and improved over time.</p><fig position="float" id="fig6" orientation="portrait"><label>Figure 6.</label><caption><p>Structural imaging reveals minor morphological changes following ILM peel in (<bold>A</bold>) M1 OD, (<bold>B</bold>) M2 OS, (<bold>C</bold>) M2 OD, (<bold>D</bold>) M3 OS, and (<bold>E</bold>) M3 OD. (<italic toggle="yes">Left</italic>) 55&#176; Color fundus images of <italic toggle="yes">white arrows</italic> indicate areas consistent with CMDSs. (<italic toggle="yes">Right</italic>) B-scan OCT of the foveal pit between 2 and 24 weeks after ILM peel and 1 to 142 days after intravitreal injection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f006.jpg"/></fig><p>Swelling of the arcuate nerve fiber layer also known as concentric macular dark spots (CMDS),<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> were observed in the color fundus images of three of the five eyes (<xref rid="fig6" ref-type="fig">Figs. 6</xref>B&#8211;<xref rid="fig6" ref-type="fig">6</xref>D, <italic toggle="yes">white arrows</italic>) surrounding the fovea and aligned with the sweep of retinal nerve fibers toward the optic disc. Shallow dimples in the RNFL were observed after ILM peel in OCT-B scan data from all animals, consistent with previous reports of disassociated optic nerve fiber layer.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref></p><p>To further investigate potential damage to the GCL or RNFL, we used fluorescence AOSLO imaging (<xref rid="fig7" ref-type="fig">Fig.&#160;7</xref>A) to investigate retinal locations containing both darkened spots in color fundus and disassociated optic nerve fiber layer in the OCT-B scan. Our findings confirmed that dimples present in the RNFL (<xref rid="fig7" ref-type="fig">Figs. 7</xref>B,&#160;<xref rid="fig7" ref-type="fig">7</xref>D) correlated with the absence of small (&lt;100&#160;&#181;m) pockets of RGCs (<xref rid="fig7" ref-type="fig">Figs. 7</xref>C,&#160;<xref rid="fig7" ref-type="fig">7</xref>E). This RGC loss was variable between animals. Animal M1 OS (<xref rid="fig7" ref-type="fig">Fig.&#160;7</xref>D, <italic toggle="yes">left</italic>) had only one hypofluorescent region near the edge of expression (<xref rid="fig7" ref-type="fig">Fig.&#160;7</xref>D, <italic toggle="yes">right</italic>), whereas other eyes had them close to the fovea, predominantly in the temporal retina. To test the connection between CMDS and the RNFL dimples visible in OCT, we investigated patches of CMDS with fluorescence AOSLO. We found that these CMDS regions were not associated with missing RGCs. For example, in M2 OS (<xref rid="fig7" ref-type="fig">Figs. 7</xref>F,&#160;<xref rid="fig7" ref-type="fig">7</xref>G) the CMDS region does not appear on the OCT as a dimple in the RNFL, nor in the AOSLO data as hypofluorescent.</p><fig position="float" id="fig7" orientation="portrait"><label>Figure 7.</label><caption><p>Circular retinal defects correspond to the absence of ganglion cell fluorescence. (<bold>A</bold>) AOSLO calcium image of two hypofluorescent areas in M3 OS. Dendrites are visible in this region. (<bold>B</bold>) Color fundus (<italic toggle="yes">top left</italic>) and cSLO BAF (<italic toggle="yes">top right</italic>) of M3 OS showing two hypofluorescent areas that are investigated with OCT (<italic toggle="yes">bottom</italic>). <italic toggle="yes">White line</italic> indicates OCT location. (<bold>C</bold>) Montaged fluorescence AOSLO image reveals dimples in OCT correspond with the two hypofluorescent areas in AOSLO. (<bold>D</bold>) Color fundus image of a retinal location with no macular dark spots but a hypofluorescent region in the cSLO BAF (<bold>E</bold>). OCT and AOSLO of the hyperfluorescent region seen in (D). (<bold>F</bold>) Color fundus image of a retinal location with CMDS streaks but no visible RNFL dimples in OCT or (<bold>G</bold>) hypofluorescent RGC expression visible in AOSLO.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="iovs-66-12-25-f007.jpg"/></fig><p>A board-certified ophthalmologist evaluated ocular inflammation using a Modified Hackett&#8211;McDonald scoring system (<xref rid="tbl2" ref-type="table">Table 2</xref>)<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> in all four eyes of animals M2 and M3 following intravitreal injection of the viral vector. In M2, inflammation was characterized principally by conjunctival congestion, swelling, and decreased corneal transparency with pigment noted on the anterior capsule of OS up to 12 weeks after injection. M3 primarily experienced decreased corneal transparency in both eyes, with OS scoring higher on the Modified Hackett-McDonald scale, indicating greater severity. Additionally, M3 developed mild conjunctival congestion and swelling, which persisted up to 7 weeks after injection. Despite temporary inflammation, GCaMP expression was maintained in all eyes for the duration of this study.</p><table-wrap position="float" content-type="18col" id="tbl2" orientation="portrait"><label>Table 2.</label><caption><p>Ocular Inflammation Scores</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="17" rowspan="1">Weeks After Injection</th></tr><tr><th rowspan="1" colspan="1">Animal</th><th rowspan="1" colspan="1">&#8722;4</th><th rowspan="1" colspan="1">&#8722;3</th><th rowspan="1" colspan="1">&#8722;2</th><th rowspan="1" colspan="1">&#8722;1</th><th rowspan="1" colspan="1">0</th><th rowspan="1" colspan="1">1</th><th rowspan="1" colspan="1">2</th><th rowspan="1" colspan="1">3</th><th rowspan="1" colspan="1">4</th><th rowspan="1" colspan="1">5</th><th rowspan="1" colspan="1">6</th><th rowspan="1" colspan="1">7</th><th rowspan="1" colspan="1">8</th><th rowspan="1" colspan="1">9</th><th rowspan="1" colspan="1">10</th><th rowspan="1" colspan="1">11</th><th rowspan="1" colspan="1">12</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">M2 OS</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">M2 OD</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">M3 OS</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">M3 OD</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr></tbody></table><table-wrap-foot><fn id="tb2fn1"><p>Inflammation after intravitreal injection of the viral vector in animals M2 and M3 was scored longitudinally by a masked board-certified ophthalmologist based on a modified Hackett&#8211;McDonald scoring system.<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> The assessment included slit lamp examination and observations of pupillary response and dilation. Scores shown are integrated from the nine numerical measures listed in the attached Modified Hackett-McDonald scoring sheet.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="sec4"><title>Discussion</title><p>Surgical removal of the ILM before intravitreal injection of a viral vector coding for GCaMP expanded the mean area of the retina accessible for optical recording from RGCs eight-fold across the five primate eyes evaluated in this study. These are the first optical measurements of RGC activity at eccentricities beyond a small (&lt;3&#176;) foveal ring that have been achieved in vivo and the first demonstration that optical recording of calcium responses from the RNFL is possible. Longitudinal recordings of calcium responses from RGCs over weeks and months showed variation but no significant long-term decline, suggesting that RGC function was not significantly compromised by the ILM peel procedure. This result is promising for future applications of ILM peeling in gene and cell therapies. In addition, we used AOSLO to investigate previously reported structural defects associated with the ILM peel procedure and observed a variable number of small hypofluorescent regions of RGC loss, more common in temporal retina and visible as depressions in the OCT images of the GCL. This minimal loss of discrete patches of RGCs may be an acceptable tradeoff, given the expanded region accessible for calcium imaging in vivo or for therapeutic applications.</p><p>The advances presented in this paper have implications for both retinal neuroscience, preclinical assessment of retinal function, and the delivery of new therapies that could use the ILM peel procedure. The ability to functionally survey large areas of the GCL beyond the fovea both in vivo and at the cellular scale could be valuable in identifying and interrogating rare classes of primate RGCs and understanding how these cells change with eccentricity. From a preclinical standpoint, the cellular scale assessment of retinal function in vivo has potential to advance our ability to characterize disease models and detect and track restored RGC function that might be spatially and temporally sporadic, for example, in the development of cell therapies. In this case, peeling the ILM would expand the available surface area for therapeutic investigation by eight-fold. Lastly surgical peel of the ILM may be a viable strategy to expand the region of the retina that can be transduced by gene therapies or receive RGC transplants. Our results suggest that RGC function is not severely impacted by this intervention in the months after surgery and for example, in the case of, optogenetic gene therapy targeting RGCs,<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> ILM peel could substantially increase the patients&#8217; restored visual angle and, therefore, the potential benefit derived from this therapy.</p><sec id="sec4-1"><title>Variability in RGC Responses Between Subjects</title><p>We observed a substantial variability in <italic toggle="yes">z-</italic>scores between animals, with subject M1 responding with significantly higher <italic toggle="yes">z</italic>-scores relative to other experimental eyes. A variety of factors could be behind this, but we note that M1 was significantly older (10 years as opposed to 4 years) and had fewer inactivating antibodies to AAV2 than the other animals (<xref rid="tbl1" ref-type="table">Table 1</xref>). Age can have an impact on innate immunity, and could have affected the efficacy of viral transduction or the degree of inflammation impacting anterior segment optics. In M1 there was also a much shorter time between ILM peel and the first intravitreal injection, minimizing any potential obstruction of viral access to the GCL by glia-mediated scar formation; although the ILM does not regrow, over time Muller glia produce a basement membrane that covers most of the exposed retina.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref></p></sec><sec id="sec4-2"><title>Functional Responses Were Obtained From the RNFL</title><p>We were able to extract functional responses from RGC axons in addition to those recorded directly from RGC somas. This was possible both in the control eye and the ILM peeled eye, but with double the Z score in ILM peeled eyes relative to the control (<xref rid="fig5" ref-type="fig">Fig.&#160;5</xref>). This finding could be explained by the increased number of GCaMP-expressing RGCs in the ILM peeled eye and, therefore, a greater number of GCaMP-expressing axons traversing the field of view. We note that the RNFL trace was dominated by an OFF response that may be explained by the stimulus design. A high photopic mean light level can drive stronger OFF responses than ON. An enlarged, panretinal stimulus could further increase the measured RNFL response by activating additional RGCs. This finding raises the possibility of RGC responses being partially contaminated by signals from the overlying RNFL; further work is required to understand the relative magnitudes of soma and RNFL responses, a ratio that is likely to vary with retinal position and focal plane. Recording directly from the RNFL may be of interest in preclinical models of glaucoma or assessing axon regeneration of transplanted ganglion cells in vivo.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> Future work may focus on segmenting responses from individual axon bundles to better understand organization of functional responses traveling to the optic disc.</p></sec><sec id="sec4-3"><title>The Ocular Inflammation Associated With Viral Vector Injections in Immunosuppressed ILM Peeled Animals Does not Prevent Functional Recording</title><p>Inflammation was observed in the weeks after viral vector injection in the eyes of M2 and M3 (<xref rid="tbl2" ref-type="table">Table 2</xref>; inflammation was not evaluated in M1). The duration and extent of inflammation varied between immune-suppressed animals, but we did not observe a substantial increase in inflammation relative to a previous report from a nonvitrectomized, non&#8211;ILM-peeled primate eye intravitreally injected with vector AAV2:CAG:GCaMP6s.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> Relative to this animal, M2 scored higher in overall inflammatory response, whereas M3 scored lower with both M2 and M3 recovering faster. The present study used a ganglion cell&#8211;specific promoter SNCG<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> instead of the ubiquitous promoter CAG, a different serotype (7m8 instead of AAV2) and GCaMP generation (GCaMP8 instead of GCaMP6) relative to the previous study, making a direct comparison challenging, but the general similarities suggest that inflammation does not preclude adoption of this technique in a preclinical context.</p></sec><sec id="sec4-4"><title>Surgical Outcomes Associated With Peeling the ILM</title><p>This study demonstrates the feasibility of using an ILM peel to expand the imaging area for the functional assessment of macaque RGCs and also provides new insight into outcomes associated with the surgery itself. Consistent with clinical literature, the most obvious consequence of ILM peel is an altered foveal contour (<xref rid="fig6" ref-type="fig">Fig.&#160;6</xref>), consistent with previously reported increase in central macular thickness.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> CMDS and disassociated optic nerve fiber layer were also observed, the latter being associated with small pockets of RGC loss and occurring more frequently in temporal retina where the RNFL is thinner.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref></p><p>Some RGC loss after ILM peeling is consistent with immunohistochemical studies of excised ILM, suggesting that RGCs can be removed during the ILM peeling process.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> In this study, M1 (<xref rid="fig4" ref-type="fig">Fig.&#160;4</xref>A; 10 years old) showed only a single focal spot of hypofluorescent RGC loss, compared with more numerous hypofluorescent regions of RGC loss present in the temporal retina of younger NHPs (<xref rid="fig4" ref-type="fig">Figs. 4</xref>B&#8211;<xref rid="fig4" ref-type="fig">4</xref>E; &#8764;4 years old). Electron microscopy studies have demonstrated that the ILM basement membrane undergoes significant age-related changes.<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> In the human eye, the ILM thickens from 70 nm at fetal stages to 300 nm by age 22 years, reaching up to 2 &#181;m by age 90 years. In addition to thickening, the ILM also becomes progressively stiffer and undergoes changes to its biochemical composition that may further decrease retinal adhesion in older animals. Although the numbers of animals are limited, we speculate that these age-related changes in ILM adherence may explain why the older animal, M1, showed more limited RGC loss relative to the younger animals in the study.</p><p>Determining the impact of ILM peeling alone on visual function is challenging as the surgical procedure is typically performed as a treatment for retinal problems rather than on otherwise healthy eyes. One study examining ILM peeling during idiopathic epiretinal membrane removal found no statistically significant difference in visual acuity between patients who underwent ILM peeling and those who did not.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> Studies examining structural retinal changes after ILM peeling have found that arcuate nerve fiber swelling<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> and dissociated optic nerve fiber layer<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> appearance have not been correlated with decreases in visual acuity, although studies suggest that there may be decreases in sensitivity.<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> The primary benefit of ILM peeling lies in expanding the visual field that is treatable with intravitreal gene therapies from the central 3&#176; of the fovea to 12&#176; in patients with profound vision loss. For patients with central retinal degeneration, it may be prudent to restrict the ILM peel only to the area requiring treatment to minimize any risk to the remaining retina. In the scenario that this treatment is being offered to patients with no central vision, the changes in the foveal contour or the loss of small patches of RGCs are of relatively little concern.</p></sec><sec id="sec4-5"><title>Alternatives to ILM Peeling</title><p>Alternative methods to overcome the barrier to viral transduction posed by the ILM in primates have been suggested including enzymatic digestion of the ILM with a nonspecific protease,<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref> photodisruption,<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref><sup>,</sup><xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> or sub-ILM injection.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> Enzymatic digestion has the advantage of not requiring surgery, but has not been attempted in NHPs, where the ILM is thicker than in small animal models. Because ILM thickness is eccentricity dependent in primates, it is not straightforward to titrate the correct dose of enzyme, risking substantial retinal damage. Photodisruption of the ILM has been tested successfully in bovine retinal explants<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> using indocyanine green, and recently this work has been extended to an in vivo rabbit model<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref>; however, further testing is necessary before it can be applied to NHP. Last, an alternative surgical strategy is sub-ILM delivery of the viral vector that may yield similar results while keeping more of the structure intact. Because the ILM is composed of Muller cell foot plates, its removal has the potential to cause Muller cell dysfunction.<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> ILM delivery is, therefore, desirable, but is surgically very challenging given the thickness of the ILM and there is a risk of delivering the viral vector subretinally or subhyloid, neither of which would target the GCL.</p></sec></sec><sec sec-type="conclusion" id="sec5"><title>Conclusions</title><p>This study demonstrates not only that the ILM peel approach allows functional recording from a larger area of the GCL in primate, but also that the recordings remain stable over time and are comparable to those in an eye with no ILM peel. As such, this technique may be of value for the preclinical evaluation of retinal function, both for detecting vision loss and assessing the impact of therapeutic interventions. For cell-based therapies where single-cell resolution is needed, a larger area to assess retinal function would greatly increase the chance of success given the potential sparse integration and uncertainty of the locus of cell delivery. Last, these data suggest that ILM peel is a viable approach for expanding the area of the GCL that is treatable by intravitreal delivery of gene therapies.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="iovs-66-12-25_s001" position="float" content-type="local-data" orientation="portrait"><caption><title>Supplement 1</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="iovs-66-12-25_s001.pdf" id="d67e1483" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="iovs-66-12-25_s002" position="float" content-type="local-data" orientation="portrait"><caption><title>Supplement 2</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="iovs-66-12-25_s002.mp4" id="d67e1487" position="anchor" mimetype="video" mime-subtype="mp4" orientation="portrait"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Qiang Yang at the University of Rochester and the Penn Vector Core (RRID: SCR_022432) at the Perelman School of Medicine, University of Pennsylvania. Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Audacious Goals Initiative funding award No. U24 EY033275 Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function, P30 EY001319 (core), and F32 EY032318 Foveal ganglion cell function in the living eye. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support was provided by an unrestricted grant to the University of Rochester Department of Ophthalmology from Research to Prevent Blindness and from a Steven E. Feldon Scholarship from the Flaum Eye Institute.</p><p content-type="COI-statement">Disclosure: <bold>H.C. Baez</bold>, None; <bold>J.M. LaPorta</bold>, None; <bold>A.D. Walker</bold>, None; <bold>W.S. Fischer</bold>, None; <bold>R. Hollar</bold>, None; <bold>S.S. Patterson</bold>, None; <bold>D.A. DiLoreto, Jr</bold>, None; <bold>V. Gullapalli</bold>, None; <bold>J.E. McGregor</bold>, None</p></ack><ref-list><title>References</title><ref id="bib1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chichilnisky</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Kalmar</surname><given-names>RS</given-names></string-name></person-group>. <article-title>Functional asymmetries in ON and OFF ganglion cells of primate retina</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2002</year>; <volume>22</volume>(<issue>7</issue>): <fpage>2737</fpage>&#8211;<lpage>2747</lpage>.<pub-id pub-id-type="pmid">11923439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.22-07-02737.2002</pub-id><pub-id pub-id-type="pmcid">PMC6758315</pub-id></mixed-citation></ref><ref id="bib2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Crook</surname><given-names>JD</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Origins of direction selectivity in the primate retina</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2022</year>; <volume>13</volume>(<issue>1</issue>): <fpage>2862</fpage>.<pub-id pub-id-type="pmid">35606344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-022-30405-5</pub-id><pub-id pub-id-type="pmcid">PMC9126974</pub-id></mixed-citation></ref><ref id="bib3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shah</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Downes</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Smithson</surname><given-names>HE</given-names></string-name>, <string-name name-style="western"><surname>Young</surname><given-names>LK</given-names></string-name></person-group>. <article-title>Adaptive optics scanning laser ophthalmoscopy in a heterogenous cohort with Stargardt disease</article-title>. <source><italic toggle="yes">Sci Rep UK</italic></source>. <year>2024</year>; <volume>14</volume>(<issue>1</issue>): <fpage>23629</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-74088-y</pub-id><pub-id pub-id-type="pmcid">PMC11464663</pub-id><pub-id pub-id-type="pmid">39384610</pub-id></mixed-citation></ref><ref id="bib4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gogliettino</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Madugula</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Grosberg</surname><given-names>LE</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>High- fidelity reproduction of visual signals by electrical stimulation in the central primate retina</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2023</year>; <volume>43</volume>(<issue>25</issue>): <fpage>4625</fpage>&#8211;<lpage>4641</lpage>.<pub-id pub-id-type="pmid">37188516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.1091-22.2023</pub-id><pub-id pub-id-type="pmcid">PMC10286946</pub-id></mixed-citation></ref><ref id="bib5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gasparini</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Tessmer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Reh</surname><given-names>M</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Transplanted human cones incorporate into the retina and function in a murine cone degeneration model</article-title>. <source><italic toggle="yes">J Clin Invest</italic></source>. <year>2022</year>; <volume>132</volume>(<issue>12</issue>): <fpage>e154619</fpage>.<pub-id pub-id-type="pmid">35482419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI154619</pub-id><pub-id pub-id-type="pmcid">PMC9197520</pub-id></mixed-citation></ref><ref id="bib6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Masella</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Dalkara</surname><given-names>D</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Imaging light responses of foveal ganglion cells in the living macaque eye</article-title>. <source><italic toggle="yes">J Neurosci</italic></source>. <year>2014</year>; <volume>34</volume>(<issue>19</issue>): <fpage>6596</fpage>&#8211;<lpage>6605</lpage>.<pub-id pub-id-type="pmid">24806684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1523/JNEUROSCI.4438-13.2014</pub-id><pub-id pub-id-type="pmcid">PMC4012315</pub-id></mixed-citation></ref><ref id="bib7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dacey</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Packer</surname><given-names>OS</given-names></string-name></person-group>. <article-title>Colour coding in the primate retina: diverse cell types and cone-specific circuitry</article-title>. <source><italic toggle="yes">Curr Opin Neurobiol</italic></source>. <year>2003</year>; <volume>13</volume>(<issue>4</issue>): <fpage>421</fpage>&#8211;<lpage>427</lpage>.<pub-id pub-id-type="pmid">12965288</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0959-4388(03)00103-x</pub-id></mixed-citation></ref><ref id="bib8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Provis</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Dubis</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Maddess</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Carroll</surname><given-names>J</given-names></string-name></person-group>. <article-title>Adaptation of the central retina for high acuity vision: cones, the fovea and the avascular zone</article-title>. <source><italic toggle="yes">Prog Retinal Eye Res</italic></source>. <year>2013</year>; <volume>35</volume>: <fpage>63</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preteyeres.2013.01.005</pub-id><pub-id pub-id-type="pmcid">PMC3658155</pub-id><pub-id pub-id-type="pmid">23500068</pub-id></mixed-citation></ref><ref id="bib9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Messaoudi</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Estep</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>SW</given-names></string-name></person-group>. <article-title>Nonhuman primate models of human immunology</article-title>. <source><italic toggle="yes">Antioxid Redox Signal</italic></source>. <year>2011</year>; <volume>14</volume>(<issue>2</issue>): <fpage>261</fpage>&#8211;<lpage>273</lpage>.<pub-id pub-id-type="pmid">20524846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/ars.2010.3241</pub-id><pub-id pub-id-type="pmcid">PMC3014769</pub-id></mixed-citation></ref><ref id="bib10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Picaud</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Dalkara</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Marazova</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Goureau</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Roska</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Sahel</surname><given-names>JA</given-names></string-name></person-group>. <article-title>The primate model for understanding and restoring vision</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci USA</italic></source>. <year>2019</year>; <volume>116</volume>(<issue>52</issue>): <fpage>26280</fpage>&#8211;<lpage>26287</lpage>.<pub-id pub-id-type="pmid">31871177</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1902292116</pub-id><pub-id pub-id-type="pmcid">PMC6936588</pub-id></mixed-citation></ref><ref id="bib11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gauvain</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Akolkar</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Chaffiol</surname><given-names>A</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates</article-title>. <source><italic toggle="yes">Commun Biol</italic></source>. <year>2021</year>; <volume>4</volume>(<issue>1</issue>): <fpage>125</fpage>.<pub-id pub-id-type="pmid">33504896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-020-01594-w</pub-id><pub-id pub-id-type="pmcid">PMC7840970</pub-id></mixed-citation></ref><ref id="bib12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ganjawala</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Fenner</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Abrams</surname><given-names>GW</given-names></string-name>, <string-name name-style="western"><surname>Pan</surname><given-names>ZH</given-names></string-name></person-group>. <article-title>Improved CoChR variants restore visual acuity and contrast sensitivity in a mouse model of blindness under ambient light conditions</article-title>. <source><italic toggle="yes">Mol Ther</italic></source>. <year>2019</year>; <volume>27</volume>(<issue>6</issue>): <fpage>1195</fpage>&#8211;<lpage>1205</lpage>.<pub-id pub-id-type="pmid">31010741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2019.04.002</pub-id><pub-id pub-id-type="pmcid">PMC6554551</pub-id></mixed-citation></ref><ref id="bib13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Le Meur</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Stieger</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>AJ</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium</article-title>. <source><italic toggle="yes">Gene Ther</italic></source>. <year>2007</year>; <volume>14</volume>(<issue>4</issue>): <fpage>292</fpage>&#8211;<lpage>303</lpage>.<pub-id pub-id-type="pmid">17024105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.gt.3302861</pub-id></mixed-citation></ref><ref id="bib14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pearson</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Barber</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Rizzi</surname><given-names>M</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Restoration of vision after transplantation of photoreceptors</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2012</year>; <volume>485</volume>(<issue>7396</issue>): <fpage>99</fpage>&#8211;<lpage>103</lpage>.<pub-id pub-id-type="pmid">22522934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature10997</pub-id><pub-id pub-id-type="pmcid">PMC3888831</pub-id></mixed-citation></ref><ref id="bib15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nikonov</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aravand</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lyubarsky</surname><given-names>A</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Restoration of vision and retinal responses after adeno-associated virus-mediated optogenetic therapy in blind dogs</article-title>. <source><italic toggle="yes">Transl Vis Sci Techn</italic></source>. <year>2022</year>; <volume>11</volume>(<issue>5</issue>): <fpage>24</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/tvst.11.5.24</pub-id><pub-id pub-id-type="pmcid">PMC9145127</pub-id><pub-id pub-id-type="pmid">35604672</pub-id></mixed-citation></ref><ref id="bib16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Roorda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Romero-Borja</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Donnelly</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Queener</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hebert</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>MCW</given-names></string-name></person-group>. <article-title>Adaptive optics scanning laser ophthalmoscopy</article-title>. <source><italic toggle="yes">Opt Express</italic></source>. <year>2002</year>; <volume>10</volume>(<issue>9</issue>): <fpage>405</fpage>&#8211;<lpage>412</lpage>.<pub-id pub-id-type="pmid">19436374</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1364/oe.10.000405</pub-id></mixed-citation></ref><ref id="bib17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McGregor</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Godat</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Dhakal</surname><given-names>KR</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Optogenetic restoration of retinal ganglion cell activity in the living primate</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2020</year>; <volume>11</volume>(<issue>1</issue>): <fpage>1703</fpage>.<pub-id pub-id-type="pmid">32245977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-020-15317-6</pub-id><pub-id pub-id-type="pmcid">PMC7125151</pub-id></mixed-citation></ref><ref id="bib18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McGregor</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Q</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Functional architecture of the foveola revealed in the living primate</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2018</year>; <volume>13</volume>(<issue>11</issue>): <fpage>e0207102</fpage>.<pub-id pub-id-type="pmid">30485298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0207102</pub-id><pub-id pub-id-type="pmcid">PMC6261564</pub-id></mixed-citation></ref><ref id="bib19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Comander</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Carvalho</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname><given-names>R</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Characterization of the limitations to gene transfer and associated inflammation following intravitreal AAV injection in nonhuman primates</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2016</year>; <volume>57</volume>(<issue>12</issue>): <fpage>771</fpage>&#8211;<lpage>771</lpage>.26927570
</mixed-citation></ref><ref id="bib20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dalkara</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kolstad</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Caporale</surname><given-names>N</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous</article-title>. <source><italic toggle="yes">Mol Ther</italic></source>. <year>2009</year>; <volume>17</volume>(<issue>12</issue>): <fpage>2096</fpage>&#8211;<lpage>2102</lpage>.<pub-id pub-id-type="pmid">19672248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mt.2009.181</pub-id><pub-id pub-id-type="pmcid">PMC2814392</pub-id></mixed-citation></ref><ref id="bib21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Igarashi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Miyake</surname><given-names>K</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Improved intravitreal AAV- mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys</article-title>. <source><italic toggle="yes">Mol Ther</italic></source>. <year>2017</year>; <volume>25</volume>(<issue>1</issue>): <fpage>296</fpage>&#8211;<lpage>302</lpage>.<pub-id pub-id-type="pmid">28129123</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2016.10.008</pub-id><pub-id pub-id-type="pmcid">PMC5363307</pub-id></mixed-citation></ref><ref id="bib22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Teo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Constable</surname><given-names>I</given-names></string-name></person-group>. <article-title>The effect of surgical removal of the internal limiting membrane on AAV vector delivery to the retina in a non-human primate model</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2018</year>; <volume>59</volume>(<issue>9</issue>): <fpage>5660</fpage>&#8211;<lpage>5660</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.18-24333</pub-id><pub-id pub-id-type="pmid">30025098</pub-id></mixed-citation></ref><ref id="bib23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Teo</surname><given-names>KYC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Barathi</surname><given-names>AV</given-names></string-name>, <string-name name-style="western"><surname>Tun</surname><given-names>SBB</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Constable</surname><given-names>IJ</given-names></string-name></person-group>. <article-title>Surgical removal of internal limiting membrane and layering of AAV vector on the retina under air enhances gene transfection in a nonhuman primate</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2018</year>; <volume>59</volume>(<issue>8</issue>): <fpage>3574</fpage>&#8211;<lpage>3583</lpage>.<pub-id pub-id-type="pmid">30025098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.18-24333</pub-id></mixed-citation></ref><ref id="bib24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Clark</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Balducci</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Pichi</surname><given-names>F</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Swelling of the arcuate nerve fiber layer after internal limiting membrane peeling</article-title>. <source><italic toggle="yes">Retina</italic></source>. <year>2012</year>; <volume>32</volume>(<issue>8</issue>): <fpage>1608</fpage>&#8211;<lpage>1613</lpage>.<pub-id pub-id-type="pmid">22495325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IAE.0b013e3182437e86</pub-id></mixed-citation></ref><ref id="bib25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ito</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Terasaki</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Takahashi</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yamakoshi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kondo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nakamura</surname><given-names>M</given-names></string-name></person-group>. <article-title>Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular holes</article-title>. <source><italic toggle="yes">Ophthalmology</italic></source>. <year>2005</year>; <volume>112</volume>(<issue>8</issue>): <fpage>1415</fpage>&#8211;<lpage>1420</lpage>.<pub-id pub-id-type="pmid">16061095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ophtha.2005.02.023</pub-id></mixed-citation></ref><ref id="bib26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rhee</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Woo</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>YS</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>KH</given-names></string-name></person-group>. <article-title>Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source>. <year>2010</year>; <volume>150</volume>(<issue>5</issue>): <fpage>701</fpage>&#8211;<lpage>709</lpage>. e701.<pub-id pub-id-type="pmid">20719296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajo.2010.05.037</pub-id></mixed-citation></ref><ref id="bib27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chan</surname><given-names>YK</given-names></string-name>, <string-name name-style="western"><surname>Dick</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>SM</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Inflammation in viral vector-mediated ocular gene therapy: a review and report from a workshop hosted by the Foundation Fighting Blindness, 9/2020</article-title>. <source><italic toggle="yes">Transl Vis Sci Technol</italic></source>. <year>2021</year>; <volume>10</volume>(<issue>4</issue>): <fpage>3</fpage>&#8211;<lpage>3</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/tvst.10.4.3</pub-id><pub-id pub-id-type="pmcid">PMC8024774</pub-id><pub-id pub-id-type="pmid">34003982</pub-id></mixed-citation></ref><ref id="bib28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Greenberg</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hunter</surname><given-names>JJ</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Intravitreal injection of AAV2 transduces macaque inner retina</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2011</year>; <volume>52</volume>(<issue>5</issue>): <fpage>2775</fpage>&#8211;<lpage>2783</lpage>.<pub-id pub-id-type="pmid">21310920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.10-6250</pub-id><pub-id pub-id-type="pmcid">PMC3088562</pub-id></mixed-citation></ref><ref id="bib29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Munger</surname><given-names>RJ</given-names></string-name></person-group>. <article-title>Veterinary ophthalmology in laboratory animal studies</article-title>. <source><italic toggle="yes">Vet Ophthalmol</italic></source>. <year>2002</year>; <volume>5</volume>(<issue>3</issue>): <fpage>167</fpage>&#8211;<lpage>175</lpage>.<pub-id pub-id-type="pmid">12236867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1463-5224.2002.00243.x</pub-id></mixed-citation></ref><ref id="bib30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gray</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Merigan</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Wolfing</surname><given-names>JI</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cells</article-title>. <source><italic toggle="yes">Opt Express</italic></source>. <year>2006</year>; <volume>14</volume>(<issue>16</issue>): <fpage>7144</fpage>&#8211;<lpage>7158</lpage>.<pub-id pub-id-type="pmid">19529085</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1364/oe.14.007144</pub-id></mixed-citation></ref><ref id="bib31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Godat</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Cottaris</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname><given-names>S</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>In vivo chromatic and spatial tuning of foveolar retinal ganglion cells in Macaca fascicularis</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2022</year>; <volume>17</volume>(<issue>11</issue>): <fpage>e0278261</fpage>.<pub-id pub-id-type="pmid">36445926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0278261</pub-id><pub-id pub-id-type="pmcid">PMC9707781</pub-id></mixed-citation></ref><ref id="bib32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Baron</surname><given-names>WS</given-names></string-name></person-group>. <article-title>Maxwellian view stimulator for electrophysiological or psychophysical work</article-title>. <source><italic toggle="yes">Appl Opt</italic></source>. <year>1973</year>; <volume>12</volume>(<issue>11</issue>): <fpage>2560</fpage>&#8211;<lpage>2562</lpage>.<pub-id pub-id-type="pmid">20125830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1364/AO.12.002560</pub-id></mixed-citation></ref><ref id="bib33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rossi</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Rangel-Fonseca</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Parkins</surname><given-names>K</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>In vivo imaging of retinal pigment epithelium cells in age related macular degeneration</article-title>. <source><italic toggle="yes">Biomed Opt Express</italic></source>. <year>2013</year>; <volume>4</volume>(<issue>11</issue>): <fpage>2527</fpage>&#8211;<lpage>2539</lpage>.<pub-id pub-id-type="pmid">24298413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1364/BOE.4.002527</pub-id><pub-id pub-id-type="pmcid">PMC3829547</pub-id></mixed-citation></ref><ref id="bib34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Thomas</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Rockwell</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Marshall</surname><given-names>WJ</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Procedure for the computation of hazards from diffusely scattering surfaces under the Z136.1-2000 American National Standard for Safe Use of Lasers</article-title>. <source><italic toggle="yes">J Laser Appl</italic></source>. <year>2007</year>; <volume>19</volume>(<issue>1</issue>): <fpage>46</fpage>&#8211;<lpage>54</lpage>.</mixed-citation></ref><ref id="bib35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Yang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nozato</surname><given-names>K</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Closed-loop optical stabilization and digital image registration in adaptive optics scanning light ophthalmoscopy</article-title>. <source><italic toggle="yes">Biomed Opt Express</italic></source>. <year>2014</year>; <volume>5</volume>(<issue>9</issue>): <fpage>3174</fpage>&#8211;<lpage>3191</lpage>.<pub-id pub-id-type="pmid">25401030</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1364/BOE.5.003174</pub-id><pub-id pub-id-type="pmcid">PMC4230869</pub-id></mixed-citation></ref><ref id="bib36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Schindelin</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Arganda-Carreras</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Frise</surname><given-names>E</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source><italic toggle="yes">Nat Methods</italic></source>. <year>2012</year>; <volume>9</volume>(<issue>7</issue>): <fpage>676</fpage>&#8211;<lpage>682</lpage>.<pub-id pub-id-type="pmid">22743772</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmcid">PMC3855844</pub-id></mixed-citation></ref><ref id="bib37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Alkabes</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Salinas</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Vitale</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Bures-Jelstrup</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nucci</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mateo</surname><given-names>C</given-names></string-name></person-group>. <article-title>En face optical coherence tomography of inner retinal defects after internal limiting membrane peeling for idiopathic macular hole</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2011</year>; <volume>52</volume>(<issue>11</issue>): <fpage>8349</fpage>&#8211;<lpage>8355</lpage>.<pub-id pub-id-type="pmid">21862645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.11-8043</pub-id></mixed-citation></ref><ref id="bib38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tadayoni</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Paques</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Massin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mouki-Benani</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mikol</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gaudric</surname><given-names>A</given-names></string-name></person-group>. <article-title>Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal</article-title>. <source><italic toggle="yes">Ophthalmology</italic></source>. <year>2001</year>; <volume>108</volume>(<issue>12</issue>): <fpage>2279</fpage>&#8211;<lpage>2283</lpage>.<pub-id pub-id-type="pmid">11733271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0161-6420(01)00856-9</pub-id></mixed-citation></ref><ref id="bib39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Christensen</surname><given-names>UC</given-names></string-name>, <string-name name-style="western"><surname>Kroyer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sander</surname><given-names>B</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Value of internal limiting membrane peeling in surgery for idiopathic macular hole stage 2 and 3: a randomised clinical trial</article-title>. <source><italic toggle="yes">Br J Ophthalmol</italic></source>. <year>2009</year>; <volume>93</volume>(<issue>8</issue>): <fpage>1005</fpage>&#8211;<lpage>1015</lpage>.<pub-id pub-id-type="pmid">19028741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjo.2008.151266</pub-id></mixed-citation></ref><ref id="bib40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sahel</surname><given-names>J-A</given-names></string-name>, <string-name name-style="western"><surname>Boulanger-Scemama</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pagot</surname><given-names>C</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Partial recovery of visual function in a blind patient after optogenetic therapy</article-title>. <source><italic toggle="yes">Nat Med</italic></source>. <year>2021</year>; <volume>27</volume>(<issue>7</issue>): <fpage>1223</fpage>&#8211;<lpage>1229</lpage>.<pub-id pub-id-type="pmid">34031601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-021-01351-4</pub-id></mixed-citation></ref><ref id="bib41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hisatomi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Notomi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tachibana</surname><given-names>T</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Ultrastructural changes of the vitreoretinal interface during long-term follow-up after removal of the internal limiting membrane</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source>. <year>2014</year>; <volume>158</volume>(<issue>3</issue>): <fpage>550</fpage>&#8211;<lpage>556</lpage>. e551.<pub-id pub-id-type="pmid">24878309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajo.2014.05.022</pub-id></mixed-citation></ref><ref id="bib42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>de Lima</surname><given-names>S</given-names></string-name></person-group>. <article-title>Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors (vol 109, pg 9149, 2012)</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci USA</italic></source>. <year>2012</year>; <volume>109</volume>(<issue>33</issue>): <fpage>13465</fpage>&#8211;<lpage>13465</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1119449109</pub-id><pub-id pub-id-type="pmcid">PMC3384191</pub-id><pub-id pub-id-type="pmid">22615390</pub-id></mixed-citation></ref><ref id="bib43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McGregor</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Kunala</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Z</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Optogenetic therapy restores retinal activity in primate for at least a year following photoreceptor ablation</article-title>. <source><italic toggle="yes">Mol Ther</italic></source>. <year>2022</year>; <volume>30</volume>(<issue>3</issue>): <fpage>1315</fpage>&#8211;<lpage>1328</lpage>.<pub-id pub-id-type="pmid">34547460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2021.09.014</pub-id><pub-id pub-id-type="pmcid">PMC8899524</pub-id></mixed-citation></ref><ref id="bib44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chaffiol</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Caplette</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Jaillard</surname><given-names>C</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina</article-title>. <source><italic toggle="yes">Mol Ther</italic></source>. <year>2017</year>; <volume>25</volume>(<issue>11</issue>): <fpage>2546</fpage>&#8211;<lpage>2560</lpage>.<pub-id pub-id-type="pmid">28807567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2017.07.011</pub-id><pub-id pub-id-type="pmcid">PMC5675708</pub-id></mixed-citation></ref><ref id="bib45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>IT</given-names></string-name></person-group>. <article-title>Outcomes of idiopathic macular epiretinal membrane removal with and without internal limiting membrane peeling: a comparative study</article-title>. <source><italic toggle="yes">Japan J Ophthalmol</italic></source>. <year>2010</year>; <volume>54</volume>(<issue>2</issue>): <fpage>129</fpage>&#8211;<lpage>134</lpage>.<pub-id pub-id-type="pmid">20401561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10384-009-0778-0</pub-id></mixed-citation></ref><ref id="bib46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nukada</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hangai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ooto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yoshikawa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yoshimura</surname><given-names>N</given-names></string-name></person-group>. <article-title>Tomographic features of macula after successful macular hole surgery</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2013</year>; <volume>54</volume>(<issue>4</issue>): <fpage>2417</fpage>&#8211;<lpage>2428</lpage>.<pub-id pub-id-type="pmid">23471893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.12-10838</pub-id></mixed-citation></ref><ref id="bib47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>La Heij</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Dieudonn&#233;</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Mooy</surname><given-names>CM</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source>. <year>2005</year>; <volume>140</volume>(<issue>6</issue>): <fpage>1123</fpage>&#8211;<lpage>1125</lpage>.<pub-id pub-id-type="pmid">16376661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajo.2005.05.054</pub-id></mixed-citation></ref><ref id="bib48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Candiello</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname><given-names>GJ</given-names></string-name>, <string-name name-style="western"><surname>Halfter</surname><given-names>W</given-names></string-name></person-group>. <article-title>Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane</article-title>. <source><italic toggle="yes">Matrix Biol</italic></source>. <year>2010</year>; <volume>29</volume>(<issue>5</issue>): <fpage>402</fpage>&#8211;<lpage>410</lpage>.<pub-id pub-id-type="pmid">20362054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.matbio.2010.03.004</pub-id></mixed-citation></ref><ref id="bib49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Azuma</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ueta</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Eguchi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aihara</surname><given-names>M</given-names></string-name></person-group>. <article-title>Effects of internal limiting membrane peeling combined with removal of idiopathic epiretinal membrane: a systematic review of literature and meta-analysis</article-title>. <source><italic toggle="yes">Retina</italic></source>. <year>2017</year>; <volume>37</volume>(<issue>10</issue>): <fpage>1813</fpage>&#8211;<lpage>1819</lpage>.<pub-id pub-id-type="pmid">28207608</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IAE.0000000000001537</pub-id></mixed-citation></ref><ref id="bib50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nukada</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hangai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ooto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yoshikawa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yoshimura</surname><given-names>N</given-names></string-name></person-group>. <article-title>Tomographic features of macula after successful macular hole surgery. Article</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2013</year>; <volume>54</volume>(<issue>4</issue>): <fpage>2417</fpage>&#8211;<lpage>2428</lpage>.<pub-id pub-id-type="pmid">23471893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.12-10838</pub-id></mixed-citation></ref><ref id="bib51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tadayoni</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Svorenova</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Erginay</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Gaudric</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Massin</surname><given-names>P</given-names></string-name></person-group>. <article-title>Decreased retinal sensitivity after internal limiting membrane peeling for macular hole surgery</article-title>. <source><italic toggle="yes">Br J Ophthalmol</italic></source>. <year>2012</year>; <volume>96</volume>(<issue>12</issue>): <fpage>1513</fpage>&#8211;<lpage>1516</lpage>.<pub-id pub-id-type="pmid">23077227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjophthalmol-2012-302035</pub-id><pub-id pub-id-type="pmcid">PMC3512349</pub-id></mixed-citation></ref><ref id="bib52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhang</surname><given-names>KY</given-names></string-name>, <string-name name-style="western"><surname>Tuffy</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Mertz</surname><given-names>JL</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Role of the internal limiting membrane in structural engraftment and topographic spacing of transplanted human stem cell-derived retinal ganglion cells</article-title>. <source><italic toggle="yes">Stem Cell Rep</italic></source>. <year>2021</year>; <volume>16</volume>(<issue>1</issue>): <fpage>149</fpage>&#8211;<lpage>167</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stemcr.2020.12.001</pub-id><pub-id pub-id-type="pmcid">PMC7897583</pub-id><pub-id pub-id-type="pmid">33382979</pub-id></mixed-citation></ref><ref id="bib53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Peynshaert</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Vanluchene</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>De Clerck</surname><given-names>K</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>ICG-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery</article-title>. <source><italic toggle="yes">J Control Release</italic></source>. <year>2022</year>; <volume>349</volume>: <fpage>315</fpage>&#8211;<lpage>326</lpage>.<pub-id pub-id-type="pmid">35803327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2022.07.002</pub-id></mixed-citation></ref><ref id="bib54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Janknecht</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Feltgen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Wesendahl</surname><given-names>T</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Internal limiting membrane ablation in pig eyes with the Er:YAG laser under perfluorodecalin</article-title>. <source><italic toggle="yes">Graefes Arch Clin Exp Ophthalmol</italic></source>. <year>2001</year>; <volume>239</volume>(<issue>9</issue>): <fpage>705</fpage>&#8211;<lpage>711</lpage>.<pub-id pub-id-type="pmid">11688672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s004170100343</pub-id></mixed-citation></ref><ref id="bib55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boye</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Witherspoon</surname><given-names>CD</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Highly efficient delivery of adeno-associated viral vectors to the primate retina</article-title>. <source><italic toggle="yes">Hum Gene Ther</italic></source>. <year>2016</year>; <volume>27</volume>(<issue>8</issue>): <fpage>580</fpage>&#8211;<lpage>597</lpage>.<pub-id pub-id-type="pmid">27439313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/hum.2016.085</pub-id><pub-id pub-id-type="pmcid">PMC4991591</pub-id></mixed-citation></ref><ref id="bib56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>De Clerck</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Vanluchene</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Braeckmans</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>De Smedt</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Remaut</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Peynshaert</surname><given-names>K</given-names></string-name></person-group>. <article-title>Characterization of enhanced lipid nanoparticle delivery after photodisruption of the inner limiting membrane</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source>. <year>2023</year>; <volume>64</volume>(<issue>8</issue>): <fpage>2614</fpage>&#8211;<lpage>2614</lpage>.</mixed-citation></ref><ref id="bib57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gandorfer</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Haritoglou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Gass</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Ulbig</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Kampik</surname><given-names>A</given-names></string-name></person-group>. <article-title>Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source>. <year>2001</year>; <volume>132</volume>(<issue>3</issue>): <fpage>431</fpage>&#8211;<lpage>433</lpage>.<pub-id pub-id-type="pmid">11530071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9394(01)01087-x</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>